Development of prediction models to select older RA patients with comorbidities for treatment with chronic low-dose glucocorticoids
暂无分享,去创建一个
W. Lems | M. Boers | F. Buttgereit | M. Heymans | M. Cutolo | P. Masaryk | M. Voshaar | Z. Szekanecz | L. Hartman | J. D. da Silva | D. van der Heijde | D. Opris-Belinski | D. Opriș-Belinski
[1] Lara A. Kahale,et al. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis , 2021, Arthritis & rheumatology.
[2] A. Cope,et al. Nonserious Infections in Patients With Rheumatoid Arthritis: Results From the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis , 2021, Arthritis & rheumatology.
[3] C. Allaart,et al. Medication adherence in older people with rheumatoid arthritis is lower according to electronic monitoring than according to pill count , 2021, Rheumatology.
[4] R. Westhovens,et al. Having a co-morbidity predicts worse outcome in early rheumatoid arthritis despite intensive treatment: a post hoc evaluation of the pragmatic randomized controlled CareRA trial. , 2021, Rheumatology.
[5] M. V. D. Loo,et al. Data Validation Infrastructure for R , 2019, J. Stat. Softw..
[6] J. Baker,et al. Risk for Serious Infection With Low-Dose Glucocorticoids in Patients With Rheumatoid Arthritis , 2020, Annals of Internal Medicine.
[7] D. Aletaha. Precision medicine and management of rheumatoid arthritis. , 2020, Journal of autoimmunity.
[8] Richard D Riley,et al. Calculating the sample size required for developing a clinical prediction model , 2020, BMJ.
[9] Tsutomu Takeuchi,et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update , 2020, Annals of the Rheumatic Diseases.
[10] M. Stevenson,et al. Assessing prognosis and prediction of treatment response in early rheumatoid arthritis: systematic reviews. , 2018, Health technology assessment.
[11] W. Lems,et al. Harm, benefit and costs associated with low-dose glucocorticoids added to the treatment strategies for rheumatoid arthritis in elderly patients (GLORIA trial): study protocol for a randomised controlled trial , 2018, Trials.
[12] P. Austin,et al. Events per variable (EPV) and the relative performance of different strategies for estimating the out-of-sample validity of logistic regression models , 2014, Statistical methods in medical research.
[13] G. Tobón,et al. Predictive value of autoantibodies from anti-CCP2, anti-MCV and anti-human citrullinated fibrinogen tests, in early rheumatoid arthritis patients with rapid radiographic progression at 1 year: results from the ESPOIR cohort , 2015, RMD Open.
[14] P. V. van Riel,et al. A Simplified Baseline Prediction Model for Joint Damage Progression in Rheumatoid Arthritis: A Step toward Personalized Medicine , 2015, The Journal of Rheumatology.
[15] T. Huizinga. Personalized medicine in rheumatoid arthritis: is the glass half full or half empty? , 2015, Journal of internal medicine.
[16] S. Saevarsdottir,et al. Current smoking status is a strong predictor of radiographic progression in early rheumatoid arthritis: results from the SWEFOT trial , 2014, Annals of the rheumatic diseases.
[17] Raveendhara R. Bannuru,et al. American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis , 2015 .
[18] C. Allaart,et al. A Multibiomarker Disease Activity Score for Rheumatoid Arthritis Predicts Radiographic Joint Damage in the BeSt Study , 2014, The Journal of Rheumatology.
[19] M. Karsdal,et al. Rheumatoid Arthritis: A Case for Personalized Health Care? , 2014, Arthritis care & research.
[20] A. Cope,et al. Clinical and Serological Predictors of Remission in Rheumatoid Arthritis Are Dependent on Treatment Regimen , 2014, The Journal of Rheumatology.
[21] Jeffrey N Katz,et al. Review: Treat to Target in Rheumatoid Arthritis: Fact, Fiction, or Hypothesis? , 2014, Arthritis & rheumatology.
[22] H. Canhão,et al. A1.1 Obesity is a risk factor for worse treatment response in rheumatoid arthritis patients- results from reuma.pt , 2014 .
[23] A. Krause,et al. Evaluation of the RABBIT Risk Score for serious infections , 2013, Annals of the rheumatic diseases.
[24] P. Sarzi-Puttini,et al. Predictors of response to anti-TNF therapy in RA patients with moderate or high DAS28 scores. , 2014, Joint, bone, spine : revue du rhumatisme.
[25] G. Deshpande,et al. SAT0039 A Prediction Rule for Sustained Remission of Rheumatoid Arthritis , 2013 .
[26] M. Boers,et al. Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2) , 2012, Annals of the rheumatic diseases.
[27] C. Spettell,et al. Use of a disease risk score to compare serious infections associated with anti–tumor necrosis factor therapy among high‐ versus lower‐risk rheumatoid arthritis patients , 2012, Arthritis care & research.
[28] C. Wijbrandts,et al. Body mass index and clinical response to infliximab in rheumatoid arthritis. , 2011, Arthritis and rheumatism.
[29] M. Boers,et al. Non-overlapping American College of Rheumatology response rates: a better way to report response in rheumatoid arthritis clinical trials. , 2010, Arthritis and rheumatism.
[30] A. Silman,et al. UvA-DARE (Digital Academic Repository) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative Aletaha, , 2010 .
[31] A. Silman,et al. Rheumatoid arthritis classifi cation criteria : an American College of Rheumatology / European League Against Rheumatism collaborative initiative , 2010 .
[32] C.J.H. Mann,et al. Clinical Prediction Models: A Practical Approach to Development, Validation and Updating , 2009 .
[33] P Tugwell,et al. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. , 2008, Arthritis and rheumatism.
[34] Olivier Meyer,et al. Prognostic factors of 10-year radiographic outcome in early rheumatoid arthritis: a prospective study , 2008, Arthritis Research & Therapy.
[35] P. Geborek,et al. Predictors of response to anti-TNF therapy according to ACR and EULAR criteria in patients with established RA: results from the South Swedish Arthritis Treatment Group Register. , 2007, Rheumatology.
[36] D. M. van der Heijde,et al. High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study , 2007, Annals of the rheumatic diseases.
[37] E. Keystone,et al. Disease activity early in the course of treatment predicts response to therapy after one year in rheumatoid arthritis patients. , 2007, Arthritis and rheumatism.
[38] M. Boers,et al. Effects of glucocorticoids on radiological progression in rheumatoid arthritis. , 2007, The Cochrane database of systematic reviews.
[39] J. Cañete,et al. Prognostic factors of radiographic progression in early rheumatoid arthritis: a two year prospective study after a structured therapeutic strategy using DMARDs and very low doses of glucocorticoids , 2006, Clinical Rheumatology.
[40] F. Guillemin,et al. Prognostic factors for joint destruction in rheumatoid arthritis: a prospective longitudinal study of 318 patients. , 2003, The Journal of rheumatology.
[41] T. Saxne,et al. Course of radiographic damage over 10 years in a cohort with early rheumatoid arthritis , 2003, Annals of the rheumatic diseases.
[42] S. Gabriel,et al. Predictors of infection in rheumatoid arthritis. , 2002, Arthritis and rheumatism.
[43] B. Dijkmans,et al. Predictors of radiographic joint damage in patients with early rheumatoid arthritis , 2001, Annals of the rheumatic diseases.
[44] M. Dougados,et al. Prognostic factors for radiographic damage in early rheumatoid arthritis: a multiparameter prospective study. , 2001, Arthritis and rheumatism.
[45] M. Suarez‐Almazor,et al. Moderate-term, low-dose corticosteroids for rheumatoid arthritis. , 1998, The Cochrane database of systematic reviews.
[46] J J Anderson,et al. Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. , 2000, Arthritis and rheumatism.
[47] M. V. van Leeuwen,et al. Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp's method (van der Heijde modification). , 1995, The Journal of rheumatology.
[48] M. Liang,et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.
[49] C. Werning. [Rheumatoid arthritis]. , 1983, Medizinische Monatsschrift fur Pharmazeuten.